ArticleFrontiers in oncology2025
Hypovitaminosis D in patients with oral leukoplakia: insights from a cross-sectional study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Vitamin D status in patients with oral leukoplakia and oral squamous cell carcinoma: a systematic review and meta-analysis.BMC oral health · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oral leukoplakia is one of the most frequent oral potentially malignant disorders. The present study aims to compare serum vitamin D levels between patients with and without oral leukoplakia, by smoking habit. Methods: This cross-sectional study involved a group of 45 cases with oral leukoplakia and a control group with 45 individuals. In both groups a pathology report was done, and for leukoplakia a binary classification of low- and high-grade epithelial dysplasia was employed. Serum 25(OH)D3 vitamin D levels, and data on smoking status, age, gender, comorbidities, and clinical and pathological characteristics were collected for both groups. Results: vitamin D levels were lower in the oral leukoplakia group with a median of 19.1 ng/ml, while the control group had a median of 24.8 ng/ml. When subdividing each group by smoking habit, the smoking case group had a median of 19.4 ng/ml (IQR: 15.7-21.5 ng/ml), the non-smoking case group had 18.8 ng/ml (IQR: 13.6-29.2 ng/ml), the smoking control group had 21.8 ng/ml (IQR: 17.5-27.3 ng/ml), and the non-smoking control group had 25.4 ng/ml (IQR: 20.4-32.9 ng/ml) (p<0.05). When comparing serum vitamin D levels, statistically significant differences were found between the smoking case group versus the non-smoking control group and between the non-smoking case group versus the non-smoking control group (p<0.05). Serum vitamin D levels by histopathological diagnosis showed no differences between leukoplakia groups. Discussion: This study shows that serum vitamin D levels were lower in patients with OL compared to those without OL, which was more evident in the smoking group. Patients with OL were previously observed to have hypovitaminosis D, without assessing smoking habits. This finding suggests a possible role of vitamin D deficiency in the development of OL, which could be more marked in smokers. This opens the possibility of future research on vitamin D as a chemopreventive agent in the malignant transformation of OL, and to evaluate the relationship between smoking and hypovitaminosis D.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.